
Red Light Holland advances psilocybin research with new shipments supporting multiple clinical trials in Canada
Red Light Holland has expanded its clinical research capabilities following its acquisition of Filament Health, supporting shipments of the botanical psilocybin drug candidate PEX010 to several Canadian institutions. These shipments back ongoing and ...

